01509nas a2200289   4500000000100000008004100001260001300042653001000055653002100065653000900086653002100095653003000116653001100146653001100157653001200168653000900180653001600189100002000205700001200225700001400237245010000251856004100351300001000392490000700402520079600409022001401205       1996                            d  c1996 Mar10aAdult10aAfrica, Northern10aAged10aDisabled Persons10aDrug Therapy, Combination10aFemale10aHumans10aleprosy10aMale10aMiddle Aged1 aTiendrebéogo A1 aToure I1 aZerbo P J00aA survey of leprosy impairments and disabilities among patients treated by MDT in Burkina Faso.  uhttp://ila.ilsl.br/pdfs/v64n1a03.pdf  a15-250 v643 a<p>Since 1990, Burkina Faso, a West African country, has carried out a national leprosy control program treating with WHO/MDT nearly 12,000 patients between 1990 and 1994. A sample survey of 600 cases among these patients showed that 29.8% were disabled cases. There was a predominance of males, older patients, the multibacillary form of leprosy, and former cases treated with dapsone before MDT. The actual rate increased 8.5% compared to the frequency of disabilities at detection (21.3%). The need for disability care was estimated, respectively, at 24.4% and 5% for primary and secondary grades of disability. These important needs were so great that the authors recommend the planning and initiation of a physical rehabilitation and disability prevention program in this country.</p>
  a0148-916X